Search engine for other government resources

Fondaparinux C31H53N3O49S8 - PubChem

Fondaparinux is a synthetic pentasaccharide which, apart from the O-methyl group at the reducing end of the molecule, consists of monomeric sugar ...
pubchem.ncbi.nlm.nih.gov/compound/fondaparinux

Fondaparinux Injection MedlinePlus Drug Information

Fondaparinux injection is used to prevent deep vein thrombosis (DVT; a blood clot, usually in the leg), which can lead to pulmonary embolism (PE; a ...
medlineplus.gov/druginfo/meds/a612026.html

Fondaparinux a new antithrombotic agent

Fondaparinux has shown efficacy in the prevention of venous thromboembolism in patients undergoing hip or knee replacement surgery. Large-scale ...
pubmed.ncbi.nlm.nih.gov/12501872/

Fondaparinux does it cause HIT Can it treat HIT

Heparin-induced thrombocytopenia (HIT) is an antibody-mediated prothrombotic disorder triggered by PF4-binding polyanions, usually heparin. The ...
pubmed.ncbi.nlm.nih.gov/21083474/

Fondaparinux a synthetic pentasaccharide the first in a ...

Fondaparinux exhibits complete bioavailability by the subcutaneous route and is rapidly absorbed, reaching its maximum concentration approximately 2 h ...
pubmed.ncbi.nlm.nih.gov/12070533/

Randomized blinded trial comparing fondaparinux with ...

Fondaparinux is a synthetic factor Xa inhibitor that has been shown to be superior to standard therapies for the prevention of venous thrombosis. We ...
pubmed.ncbi.nlm.nih.gov/15781750/

Fondaparinux in acute coronary syndromes

Fondaparinux is a synthetic pentasaccharide which specifically targets factor Xa of the coagulation cascade. It has been effectively used in the ...
pubmed.ncbi.nlm.nih.gov/19929450/

PDF PRESCRIBING INFORMATION ARIXTRA

system, contains 2.5 mg of fondaparinux sodium in 0.5 mL, 5.0 mg of fondaparinux sodium in 0.4 mL, 7.5 mg of fondaparinux sodium in 0.6 mL or 10.0 mg ...
www.accessdata.fda.gov/drugsatfda_docs/label/2005/021345s010lbl.pdf

Fondaparinux inyectable MedlinePlus medicinas

El fondaparinux inyectable se usa para prevenir la trombosis venosa profunda (DVT, por sus siglas en ingls; un cogulo de sangre, por lo general, en ...
medlineplus.gov/spanish/druginfo/meds/a612026-es.html

Comparison of fondaparinux and enoxaparin in acute ...

Fondaparinux was associated with a significantly reduced number of deaths at 30 days (295 vs. 352, P=0.02) and at 180 days (574 vs. 638, P=0.05) ...
pubmed.ncbi.nlm.nih.gov/?term=16537663

Fondaparinux sodium C31H43N3Na10O49S8 - PubChem

Fondaparinux Sodium is the sodium salt form of fondaparinux, a synthetic glucopyranoside with antithrombotic activity.Fondaparinux sodium selectively ...
pubchem.ncbi.nlm.nih.gov/compound/Fondaparinux-sodium

Fondaparinux a pharmacoeconomic review of its use in the ...

Fondaparinux (Arixtra) is an anticoagulant that selectively inhibits activated factor X, thereby interrupting the blood coagulation cascade. In ...
pubmed.ncbi.nlm.nih.gov/20617858/

Update on fondaparinux role in management of ...

Fondaparinux is the first selective inhibitor of the coagulation factor Xa which is commercially available for clinical use. It has been approved for ...
pubmed.ncbi.nlm.nih.gov/20184552/

Use of Fondaparinux Following Elective Lumbar Spine ...

Patients receiving fondaparinux had lower rates of symptomatic DVT and PE and a favorable complication profile when compared with matched controls ...
pubmed.ncbi.nlm.nih.gov/32905722/

Is there a role for fondaparinux in perioperative bridging

Fondaparinux's extended half-life of 17-21 hours complicates its use as a perioperative bridging therapy. The ideal time for discontinuation before ...
pubmed.ncbi.nlm.nih.gov/21164063/

Fondaparinux therapy in a hemodialysis patient with ...

Fondaparinux was used in a hemodialysis patient with HIT II without the development of thromboembolic, hemodialysis-clotting, thrombocytopenic, or ...
pubmed.ncbi.nlm.nih.gov/20554593/

DailyMed - FONDAPARINUX SODIUM injection solution

Fondaparinux sodium injection is provided in a single-dose, prefilled syringe affixed with an automatic needle protection system. Fondaparinux sodium ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ea61d0d-4403-4d9f-a946-85a459cc0aa0

FondaKIDS a prospective pharmacokinetic and safety study ...

Dosing of fondaparinux at 0.1 mg/kg once daily in children resulted in PK profiles comparable to those in adults receiving standard dosing. Fondaparin ...
pubmed.ncbi.nlm.nih.gov/21319285/

Initial anticoagulation in patients with pulmonary ...

The initial treatment of haemodynamically stable patients with pulmonary embolism (PE) has dramatically changed since the introduction of low ...
pubmed.ncbi.nlm.nih.gov/28593681/

Effect of low molecular weight heparin dalteparin and ...

Fondaparinux is a new antithrombotic drug that specifically inhibits factor Xa. Because of the known interactions of other antithrombotic agents with ...
pubmed.ncbi.nlm.nih.gov/15584059/